- Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules
Name Details
Name | Start Date | End Date | |
---|---|---|---|
Name | Current Name Sodium glycerophosphate 4.32g/20ml solution for infusion ampoules | Start Date 08-02-2022 | End Date |
Abbreviated Name | Abbreviated Name Sodium glycerophosphate 4.32g/20ml inf ampoules | Start Date 08-02-2022 |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 20
- UDFS UOM
- ml
- Unit Dose UOM
- ampoule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intravenous
- Form
- Solution for infusion
- Ontology Form/Route
- solutioninfusion.intravenous
- Name Basis
- Other
Codes
- ATC Code
- B05XA14
- BNF Codes
-
- BNF code 09050201
Code | Start Date | End Date |
---|---|---|
40518311000001107 | 08-02-2022 |
VMP Ingredients
Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
---|---|---|---|---|
Sodium glycerophosphate pentahydrate | Based on Base Substance | Sodium glycerophosphate | 216 mg | 1 ml |
Name
Sodium glycerophosphate pentahydrate
Basis of strength description
Based on Base Substance
BOSS
Sodium glycerophosphate
Strength and UOM (Nmr)
216
Strength and UOM (Dmr)
1
Parent Products
-
VTMSodium glycerophosphate
-
VMP(Current) Sodium glycerophosphate 4.32g/20ml s...
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
---|---|---|
1 ampoule | ||
20 ampoule |